Wedbush Raises Watts Water Technologies' (WTS) Price Target on Better Than Expected 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
KeyBanc Downgrades Watts Waters (WTS) to Sector Weight
February 17, 2016 1:43 PM ESTKeyBanc downgraded Watts Waters (NYSE: WTS) from Overweight to Sector Weight. Analyst Jeffrey D. Hammond expressed concern that 2016 could be a transition year.
"We are downgrading shares of WTS to Sector Weight (from Overweight), reflective of the stock reaching our $53 price target,... More
Watts Water Technologies (WTS) Tops Q4 EPS by 7c
February 16, 2016 5:18 PM ESTWatts Water Technologies (NYSE: WTS) reported Q4 EPS of $0.59, $0.07 better than the analyst estimate of $0.52. Revenue for the quarter came in at $358 million versus the consensus estimate of $335.7 million.
For earnings history and earnings-related data on Watts Water Technologies (WTS) click here.
... MoreTrading Radar for 2/17: Marriott (MAR), NVIDIA (NVDA), Priceline (PCLN), Barrick Gold (ABX), Albemarle (ALB) Report
February 16, 2016 3:29 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
